Vitucci E, Carberry C, Payton A, Herring L, Mordant A, Kim Y
Environ Res. 2024; 264(Pt 2):120395.
PMID: 39571711
PMC: 11694228.
DOI: 10.1016/j.envres.2024.120395.
Bartel S, Wolters J, Noor H, Rafie K, Fang J, Kirchner B
Cells. 2024; 13(11.
PMID: 38891077
PMC: 11171984.
DOI: 10.3390/cells13110945.
Gonzalez-Ruiz J, Baccarelli A, Cantu-de-Leon D, Prada D
Curr Environ Health Rep. 2023; 10(4):478-489.
PMID: 38052753
PMC: 10822800.
DOI: 10.1007/s40572-023-00421-8.
Vitucci E, Carberry C, Payton A, Herring L, Mordant A, McCullough S
iScience. 2023; 26(11):108162.
PMID: 37920665
PMC: 10618692.
DOI: 10.1016/j.isci.2023.108162.
Cai Y, Chen K, Liu C, Qu X
Bioact Mater. 2023; 28:243-254.
PMID: 37292231
PMC: 10245071.
DOI: 10.1016/j.bioactmat.2023.04.019.
Epigenetic regulation of pulmonary inflammation.
Ahmad S, Zhang X, Ahmad A
Semin Cell Dev Biol. 2023; 154(Pt C):346-354.
PMID: 37230854
PMC: 10592630.
DOI: 10.1016/j.semcdb.2023.05.003.
The Tricky Connection between Extracellular Vesicles and Mitochondria in Inflammatory-Related Diseases.
Di Mambro T, Pellielo G, Agyapong E, Carinci M, Chianese D, Giorgi C
Int J Mol Sci. 2023; 24(9).
PMID: 37175888
PMC: 10179665.
DOI: 10.3390/ijms24098181.
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.
Koustas E, Trifylli E, Sarantis P, Papadopoulos N, Papanikolopoulos K, Aloizos G
Int J Mol Sci. 2023; 24(8).
PMID: 37108330
PMC: 10138911.
DOI: 10.3390/ijms24087168.
"Liquid biopsy" - extracellular vesicles as potential novel players towards precision medicine in asthma.
Ambrozej D, Stelmaszczyk-Emmel A, Czystowska-Kuzmicz M, Feleszko W
Front Immunol. 2022; 13:1025348.
PMID: 36466836
PMC: 9714548.
DOI: 10.3389/fimmu.2022.1025348.
Exosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis.
Negrete-Garcia M, de Jesus Ramos-Abundis J, Alvarado-Vasquez N, Montes-Martinez E, Montano M, Ramos C
Int J Mol Sci. 2022; 23(19).
PMID: 36232350
PMC: 9569972.
DOI: 10.3390/ijms231911047.
Extracellular vesicle-induced cyclic AMP signaling.
Bhadra A, Scruggs A, Leavesley S, Annamdevula N, George A, Britain A
Cell Signal. 2022; 95:110348.
PMID: 35504529
PMC: 10676271.
DOI: 10.1016/j.cellsig.2022.110348.
Pregnancy-associated plasma protein-A (PAPP-A) is a key component of an interactive cellular mechanism promoting pulmonary fibrosis.
Bale L, Schafer M, Atkinson E, Le Brasseur N, Haak A, Oxvig C
J Cell Physiol. 2022; 237(4):2220-2229.
PMID: 35098542
PMC: 9050837.
DOI: 10.1002/jcp.30687.
Distinct Exosomal miRNA Profiles from BALF and Lung Tissue of COPD and IPF Patients.
Kaur G, Maremanda K, Campos M, Chand H, Li F, Hirani N
Int J Mol Sci. 2021; 22(21).
PMID: 34769265
PMC: 8584050.
DOI: 10.3390/ijms222111830.
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care.
Burke H, Wilkinson T
Eur Respir Rev. 2021; 30(160).
PMID: 34415848
PMC: 9488970.
DOI: 10.1183/16000617.0041-2021.
Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?.
Cereta A, Oliveira V, Costa I, Afonso J, Fonseca A, de Souza A
Front Pharmacol. 2021; 12:648506.
PMID: 33959015
PMC: 8094181.
DOI: 10.3389/fphar.2021.648506.
EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases.
Zareba L, Szymanski J, Homoncik Z, Czystowska-Kuzmicz M
Int J Mol Sci. 2021; 22(7).
PMID: 33915715
PMC: 8036254.
DOI: 10.3390/ijms22073651.
Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.
Velazquez-Diaz P, Nakajima E, Sorkhdini P, Hernandez-Gutierrez A, Eberle A, Yang D
Front Pharmacol. 2021; 12:644671.
PMID: 33841163
PMC: 8028140.
DOI: 10.3389/fphar.2021.644671.
Role of extracellular vesicles in chronic lung disease.
Trappe A, Donnelly S, McNally P, Coppinger J
Thorax. 2021; 76(10):1047-1056.
PMID: 33712504
PMC: 8461402.
DOI: 10.1136/thoraxjnl-2020-216370.
Extracellular Vesicles in Allergic Rhinitis and Asthma and Laboratory Possibilities for Their Assessment.
Demkow U, Stelmaszczyk-Emmel A
Int J Mol Sci. 2021; 22(5).
PMID: 33668821
PMC: 7956366.
DOI: 10.3390/ijms22052273.
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation.
Frohlich E
Pharmaceutics. 2021; 13(2).
PMID: 33562240
PMC: 7915745.
DOI: 10.3390/pharmaceutics13020232.